Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
16.92
-0.22 (-1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed
Medifast Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 674.48 | 1,072 | 1,599 | 1,526 | 934.84 | 713.67 | Upgrade
|
| Revenue Growth (YoY) | -44.64% | -32.94% | 4.75% | 63.25% | 30.99% | 42.45% | Upgrade
|
| Cost of Revenue | 176.7 | 296.2 | 445.97 | 398.49 | 237.03 | 176.81 | Upgrade
|
| Gross Profit | 497.77 | 775.85 | 1,153 | 1,128 | 697.82 | 536.86 | Upgrade
|
| Selling, General & Admin | 469.93 | 644.85 | 951.11 | 906.96 | 560.86 | 443.12 | Upgrade
|
| Research & Development | 4.5 | 4.6 | 4.5 | 4.4 | 2.8 | 2.7 | Upgrade
|
| Operating Expenses | 474.43 | 649.45 | 955.61 | 911.36 | 563.66 | 445.82 | Upgrade
|
| Operating Income | 23.35 | 126.4 | 197 | 216.24 | 134.16 | 91.04 | Upgrade
|
| Interest Expense | - | - | -0.7 | -0.23 | - | - | Upgrade
|
| Interest & Investment Income | 5.03 | 2.49 | - | - | 0.25 | 1.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.56 | -0.1 | -0.05 | 0.12 | -0.14 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | 24.82 | 128.8 | 196.25 | 216.13 | 134.27 | 92.36 | Upgrade
|
| Merger & Restructuring Charges | - | - | -12.2 | - | - | - | Upgrade
|
| Asset Writedown | -11.69 | - | - | - | - | - | Upgrade
|
| Pretax Income | 12.31 | 128.8 | 184.06 | 216.13 | 134.27 | 92.36 | Upgrade
|
| Income Tax Expense | 4.99 | 29.38 | 40.49 | 52.1 | 31.41 | 14.45 | Upgrade
|
| Earnings From Continuing Operations | 7.33 | 99.42 | 143.57 | 164.03 | 102.86 | 77.92 | Upgrade
|
| Net Income | 7.33 | 99.42 | 143.57 | 164.03 | 102.86 | 77.92 | Upgrade
|
| Net Income to Common | 7.33 | 99.42 | 143.57 | 164.03 | 102.86 | 77.92 | Upgrade
|
| Net Income Growth | -93.89% | -30.75% | -12.48% | 59.47% | 32.01% | 39.66% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 12 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | 0.03% | -3.15% | -4.55% | -0.31% | -2.20% | 0.31% | Upgrade
|
| EPS (Basic) | 0.67 | 9.13 | 12.82 | 14.01 | 8.74 | 6.62 | Upgrade
|
| EPS (Diluted) | 0.67 | 9.10 | 12.73 | 13.89 | 8.68 | 6.43 | Upgrade
|
| EPS Growth | -93.92% | -28.52% | -8.35% | 60.02% | 34.99% | 39.18% | Upgrade
|
| Free Cash Flow | 33.83 | 141.17 | 177.89 | 60.34 | 139.31 | 74.2 | Upgrade
|
| Free Cash Flow Per Share | 3.09 | 12.93 | 15.78 | 5.11 | 11.76 | 6.12 | Upgrade
|
| Dividend Per Share | - | 4.950 | 6.560 | 5.680 | 4.520 | 3.380 | Upgrade
|
| Dividend Growth | - | -24.54% | 15.49% | 25.66% | 33.73% | 54.34% | Upgrade
|
| Gross Margin | 73.80% | 72.37% | 72.10% | 73.89% | 74.65% | 75.22% | Upgrade
|
| Operating Margin | 3.46% | 11.79% | 12.32% | 14.17% | 14.35% | 12.76% | Upgrade
|
| Profit Margin | 1.09% | 9.27% | 8.98% | 10.75% | 11.00% | 10.92% | Upgrade
|
| Free Cash Flow Margin | 5.02% | 13.17% | 11.13% | 3.95% | 14.90% | 10.40% | Upgrade
|
| EBITDA | 27.03 | 139.51 | 207.98 | 223.05 | 138.48 | 95.66 | Upgrade
|
| EBITDA Margin | 4.01% | 13.01% | 13.01% | 14.62% | 14.81% | 13.40% | Upgrade
|
| D&A For EBITDA | 3.69 | 13.11 | 10.98 | 6.81 | 4.32 | 4.62 | Upgrade
|
| EBIT | 23.35 | 126.4 | 197 | 216.24 | 134.16 | 91.04 | Upgrade
|
| EBIT Margin | 3.46% | 11.79% | 12.32% | 14.17% | 14.35% | 12.76% | Upgrade
|
| Effective Tax Rate | 40.51% | 22.81% | 22.00% | 24.11% | 23.39% | 15.64% | Upgrade
|
| Advertising Expenses | - | 3.4 | 1.7 | 1.6 | 4.4 | 5.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.